A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
<h4>Background</h4>Viral myocarditis, which is most prevalently caused by Coxsackievirus B3 (CVB3) infection, is a serious clinical condition characterized by cardiac inflammation. However, efficient therapies targeting inflammation are still lacking and much needed. A20, also known as t...
Guardado en:
Autores principales: | Jun Gui, Yan Yue, Ruizhen Chen, Wei Xu, Sidong Xiong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c00d753cc25a45b5a4ea41a5fc9a2e90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis
por: Ninaad Lasrado, et al.
Publicado: (2021) -
Mt10-CVB3 Vaccine Virus Protects against CVB4 Infection by Inducing Cross-Reactive, Antigen-Specific Immune Responses
por: Ninaad Lasrado, et al.
Publicado: (2021) -
Dissection and function of autoimmunity-associated TNFAIP3 (A20) gene enhancers in humanized mouse models
por: Upneet K. Sokhi, et al.
Publicado: (2018) -
Dexmedetomidine inhibits the NF-κB pathway and NLRP3 inflammasome to attenuate papain-induced osteoarthritis in rats
por: Fang Cheng, et al.
Publicado: (2019) -
A RG-II type polysaccharide purified from Aconitum coreanum alleviates lipopolysaccharide-induced inflammation by inhibiting the NF-κB signal pathway.
por: Xiaojun Li, et al.
Publicado: (2014)